{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:30:20Z","timestamp":1793179820907,"version":"4.5.0"},"reference-count":124,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with Cushing disease (CD) may present with both chronic and acute perioperative complications that necessitate multidisciplinary care. This review highlights several objectives for these patients before and after transsphenoidal surgery. Preoperative management includes treatment of electrolyte disturbances, cardiovascular comorbidities, prediabetes\/diabetes, as well as prophylactic consideration(s) for thromboembolism and infection(s). Preoperative medical therapy (PMT) could prove beneficial in patients with severe hypercortisolism or in cases of delayed surgery. Some centers use PMT routinely, although the clinical benefit for all patients is controversial. In this setting, steroidogenesis inhibitors are preferred because of rapid and potent inhibition of cortisol secretion. If glucocorticoids (GCs) are not used perioperatively, an immediate remission assessment postoperatively is possible. However, perioperative GC replacement is sometimes necessary for clinically unstable or medically pretreated patients and for those patients with surgical complications. A nadir serum cortisol of less than 2 to 5\u00b5g\/dL during 24 to 74 hours postoperatively is generally accepted as remission; higher values suggest nonremission, while a few patients may display delayed remission. If remission is not achieved, additional treatments are pursued. The early postoperative period necessitates multidisciplinary awareness for early diagnosis of adrenal insufficiency (AI) to avoid adrenal crisis, which may also be potentiated by acute postoperative complications. Preferred GC replacement is hydrocortisone, if available. Assessment of recovery from postoperative AI should be undertaken periodically. Other postoperative targets include decreasing antihypertensive\/diabetic therapy if in remission, thromboprophylaxis, infection prevention\/treatment, and management of electrolyte disturbances and\/or potential pituitary deficiencies. Evaluation of recovery of thyroid, gonadal, and growth hormone deficiencies should also be performed during the following months postoperatively.<\/jats:p>","DOI":"10.1210\/jendso\/bvac010","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T16:38:17Z","timestamp":1643387897000},"source":"Crossref","is-referenced-by-count":37,"title":["Perioperative Management of a Patient With Cushing Disease"],"prefix":"10.1210","volume":"6","author":[{"given":"Elena V","family":"Varlamov","sequence":"first","affiliation":[{"name":"Departments of Medicine (Endocrinology, Diabetes and Clinical Nutrition) and Neurological Surgery, and Pituitary Center, Oregon Health & Science University, Portland, Oregon 97239, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1918-1959","authenticated-orcid":false,"given":"Greisa","family":"Vila","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, W\u00e4hringer G\u00fcrtel 18-20, A-1090, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-6289","authenticated-orcid":false,"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[{"name":"Departments of Medicine (Endocrinology, Diabetes and Clinical Nutrition) and Neurological Surgery, and Pituitary Center, Oregon Health & Science University, Portland, Oregon 97239, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"issue":"7","key":"2022021511371258900_CIT0001","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing\u2019s syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"2022021511371258900_CIT0002","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1530\/EJE-20-1309","article-title":"Management of endocrine disease: cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing\u2019s syndrome: a practical approach","volume":"184","author":"Varlamov","year":"2021","journal-title":"Eur J Endocrinol."},{"issue":"8","key":"2022021511371258900_CIT0003","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022021511371258900_CIT0004","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"2022021511371258900_CIT0005","doi-asserted-by":"crossref","first-page":"e2035","DOI":"10.1210\/clinem\/dgab058","article-title":"Acute and life-threatening complications in Cushing syndrome: prevalence, predictors, and mortality","volume":"106","author":"Schernthaner-Reiter","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2022021511371258900_CIT0006","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022021511371258900_CIT0007","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-19-0464","article-title":"High mortality within 90 days of diagnosis in patients with Cushing\u2019s syndrome: results from the ERCUSYN registry","volume":"181","author":"Valassi","year":"2019","journal-title":"Eur J Endocrinol."},{"issue":"8","key":"2022021511371258900_CIT0008","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1210\/clinem\/dgaa291","article-title":"Excess morbidity persists in patients with Cushing\u2019s disease during long-term remission: a Swedish nationwide study","volume":"105","author":"Papakokkinou","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2022021511371258900_CIT0009","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022021511371258900_CIT0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/2042018816687240","article-title":"Current best practice in the management of patients after pituitary surgery","volume":"8","author":"Prete","year":"2017","journal-title":"Ther Adv Endocrinol Metab."},{"issue":"1","key":"2022021511371258900_CIT0011","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1210\/clinem\/dgaa773","article-title":"Postoperative day 1 morning cortisol value as a biomarker to predict long-term remission of Cushing disease","volume":"106","author":"Wang","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022021511371258900_CIT0012","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.4158\/EP161512.DSCR","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: diagnosis of recurrence in Cushing disease","volume":"22","author":"Fleseriu","year":"2016","journal-title":"Endocr Pract."},{"issue":"3","key":"2022021511371258900_CIT0013","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/EJE-15-0308","article-title":"Mechanisms in endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect","volume":"173","author":"Isidori","year":"2015","journal-title":"Eur J Endocrinol."},{"key":"2022021511371258900_CIT0014","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fendo.2018.00805","article-title":"Hypercoagulability and risk of venous thromboembolic events in endogenous Cushing\u2019s syndrome: a systematic meta-analysis","volume":"9","author":"Wagner","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"3","key":"2022021511371258900_CIT0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00001721-199904000-00006","article-title":"Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing\u2019s syndrome","volume":"10","author":"Casonato","year":"1999","journal-title":"Blood Coagul Fibrinolysis."},{"issue":"2","key":"2022021511371258900_CIT0016","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF03345709","article-title":"Blood coagulation and fibrinolysis in patients with Cushing\u2019s syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels","volume":"32","author":"Erem","year":"2009","journal-title":"J Endocrinol Invest."},{"issue":"1","key":"2022021511371258900_CIT0017","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12020-009-9186-y","article-title":"Hypercoagulability in Cushing\u2019s syndrome: the role of specific haemostatic and fibrinolytic markers","volume":"36","author":"Kastelan","year":"2009","journal-title":"Endocrine."},{"issue":"8","key":"2022021511371258900_CIT0018","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jc.2009-0290","article-title":"Hypercoagulable state in Cushing\u2019s syndrome: a systematic review","volume":"94","author":"Van Zaane","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022021511371258900_CIT0019","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1507\/endocrj.K09E-260","article-title":"Endothelial dysfunction associated with hypercortisolism is reversible in Cushing\u2019s syndrome","volume":"57","author":"Akaza","year":"2010","journal-title":"Endocr J."},{"key":"2022021511371258900_CIT0020","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/978-3-319-48382-5_15","article-title":"Endothelial dysfunction in obesity","volume":"960","author":"Engin","year":"2017","journal-title":"Adv Exp Med Biol."},{"issue":"1","key":"2022021511371258900_CIT0021","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","article-title":"Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies","volume":"17","author":"Kaur","year":"2018","journal-title":"Cardiovasc Diabetol."},{"key":"2022021511371258900_CIT0022","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/5584_2016_90","article-title":"Endothelial dysfunction and hypertension","volume":"956","author":"Konukoglu","year":"2017","journal-title":"Adv Exp Med Biol."},{"issue":"2","key":"2022021511371258900_CIT0023","doi-asserted-by":"crossref","first-page":"bvz033","DOI":"10.1210\/jendso\/bvz033","article-title":"Hypercoagulability in Cushing syndrome, prevalence of thrombotic events: a large, single-center, retrospective study","volume":"4","author":"Suarez","year":"2020","journal-title":"J Endocr Soc."},{"issue":"1","key":"2022021511371258900_CIT0024","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hoc.2006.11.013","article-title":"The balance of thrombosis and hemorrhage in surgery","volume":"21","author":"Adams","year":"2007","journal-title":"Hematol Oncol Clin North Am."},{"issue":"4","key":"2022021511371258900_CIT0025","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11102-014-0600-y","article-title":"Perioperative thromboprophylaxis in Cushing\u2019s disease: what we did and what we are doing?","volume":"18","author":"Barbot","year":"2015","journal-title":"Pituitary."},{"issue":"8","key":"2022021511371258900_CIT0026","first-page":"3662","article-title":"Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing\u2019s syndrome","volume":"87","author":"Boscaro","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"2022021511371258900_CIT0027","author":"Xeris Pharmaceuticals","year":"2021"},{"key":"2022021511371258900_CIT0028","author":"Lexi-drugs."},{"issue":"4","key":"2022021511371258900_CIT0029","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s10143-019-01132-1","article-title":"Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model","volume":"43","author":"Barbot","year":"2020","journal-title":"Neurosurg Rev."},{"key":"2022021511371258900_CIT0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000314213","article-title":"Pathophysiology of dyslipidemia in Cushing\u2019s syndrome","volume":"92","author":"Arnaldi","year":"2010","journal-title":"Neuroendocrinology."},{"key":"2022021511371258900_CIT0031","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000486002","article-title":"Metabolic syndrome in Cushing\u2019s syndrome patients","volume":"49","author":"Ferrau","year":"2018","journal-title":"Front Horm Res."},{"issue":"3","key":"2022021511371258900_CIT0032","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1210\/er.2016-1105","article-title":"Glucose metabolism abnormalities in Cushing syndrome: from molecular basis to clinical management","volume":"38","author":"Scaroni","year":"2017","journal-title":"Endocr Rev."},{"issue":"9","key":"2022021511371258900_CIT0033","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tem.2020.04.004","article-title":"The immune system in Cushing\u2019s syndrome","volume":"31","author":"Hasenmajer","year":"2020","journal-title":"Trends Endocrinol Metab."},{"issue":"5","key":"2022021511371258900_CIT0034","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1210\/jc.2012-3754","article-title":"Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography","volume":"98","author":"Neary","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022021511371258900_CIT0035","doi-asserted-by":"crossref","first-page":"101380","DOI":"10.1016\/j.beem.2020.101380","article-title":"Cushing\u2019s syndrome: overview of clinical presentation, diagnostic tools and complications","volume":"34","author":"Barbot","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"2","key":"2022021511371258900_CIT0036","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00045391-200103000-00006","article-title":"Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography","volume":"8","author":"Yelamanchi","year":"2001","journal-title":"Am J Ther."},{"issue":"12","key":"2022021511371258900_CIT0037","first-page":"3617","article-title":"11 beta-Hydroxysteroid dehydrogenase activity in Cushing\u2019s syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome","volume":"80","author":"Stewart","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022021511371258900_CIT0038","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4158\/EP12149.RA","article-title":"A new therapeutic approach in the medical treatment of Cushing\u2019s syndrome: glucocorticoid receptor blockade with mifepristone","volume":"19","author":"Fleseriu","year":"2013","journal-title":"Endocr Pract."},{"issue":"1","key":"2022021511371258900_CIT0039","doi-asserted-by":"crossref","first-page":"101490","DOI":"10.1016\/j.beem.2021.101490","article-title":"Updates in adrenal steroidogenesis inhibitors for Cushing\u2019s syndrome\u2013a practical guide","volume":"35","author":"Varlamov","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"9","key":"2022021511371258900_CIT0040","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S2213-8587(20)30240-0","article-title":"Efficacy and safety of osilodrostat in patients with Cushing\u2019s disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase","volume":"8","author":"Pivonello","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2022021511371258900_CIT0041","article-title":"Effect of osilodrostat on clinical signs, physical features and health-related quality of life (HRQoL) by degree of mUFC control in patients with Cushing\u2019s disease (CD): results from the LINC 3 study 2021","author":"Pivonello","year":"2021"},{"issue":"4","key":"2022021511371258900_CIT0042","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ecl.2019.08.005","article-title":"Hypertension and cardiovascular mortality in patients with Cushing syndrome","volume":"48","author":"Nieman","year":"2019","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"8","key":"2022021511371258900_CIT0043","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11739-019-02191-4","article-title":"Aspirin in primary prevention: the triumph of clinical judgement over complex equations","volume":"14","author":"Santilli","year":"2019","journal-title":"Intern Emerg Med."},{"key":"2022021511371258900_CIT0044","doi-asserted-by":"crossref","first-page":"S125-","DOI":"10.2337\/dc21-S010","article-title":"10. Cardiovascular disease and risk management: Standards of Medical Care in Diabetes\u20132021","volume":"44","author":"American Diabetes Association.","year":"2021","journal-title":"Diabetes Care."},{"issue":"10","key":"2022021511371258900_CIT0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11892-019-1206-6","article-title":"Aspirin for primary prevention of cardiovascular disease in diabetes: a review of the evidence","volume":"19","author":"Al-Sofiani","year":"2019","journal-title":"Curr Diab Rep."},{"issue":"19","key":"2022021511371258900_CIT0046","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2015.15629","article-title":"Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US Preventive Services Task Force","volume":"316","author":"Chou","year":"2016","journal-title":"JAMA."},{"key":"2022021511371258900_CIT0047","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.2337\/dc21-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes\u20132021","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care."},{"issue":"2","key":"2022021511371258900_CIT0048","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40618-015-0404-6","article-title":"Italian Society for the Study of Diabetes (SID)\/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing\u2019s syndrome and acromegaly","volume":"39","author":"Baroni","year":"2016","journal-title":"J Endocrinol Invest."},{"issue":"3","key":"2022021511371258900_CIT0049","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MED.0000000000000537","article-title":"Glucose metabolism in Cushing\u2019s syndrome","volume":"27","author":"Sharma","year":"2020","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"4","key":"2022021511371258900_CIT0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S2213-8587(20)30021-8","article-title":"Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial","volume":"8","author":"Pernicova","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2022021511371258900_CIT0051","author":"IBM Micromedex."},{"key":"2022021511371258900_CIT0052","author":"Lexi-drugs."},{"key":"2022021511371258900_CIT0053","author":"IBM Micromedex."},{"key":"2022021511371258900_CIT0054","author":"IBM Micromedex."},{"issue":"4","key":"2022021511371258900_CIT0055","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/BF03345431","article-title":"Advances in the epidemiology, pathogenesis, and management of Cushing\u2019s syndrome complications","volume":"35","author":"Arnaldi","year":"2012","journal-title":"J Endocrinol Invest."},{"issue":"1","key":"2022021511371258900_CIT0056","doi-asserted-by":"crossref","first-page":"ofx002","DOI":"10.1093\/ofid\/ofx002","article-title":"Characteristics and mortality of Pneumocystis pneumonia in patients with Cushing\u2019s syndrome: a plea for timely initiation of chemoprophylaxis","volume":"4","author":"van Halem","year":"2017","journal-title":"Open Forum Infect Dis."},{"issue":"12b","key":"2022021511371258900_CIT0057","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/imj.12599","article-title":"Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014","volume":"44","author":"Cooley","year":"2014","journal-title":"Intern Med J."},{"issue":"1","key":"2022021511371258900_CIT0058","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0039-3399559","article-title":"Pneumocystis jiroveci","volume":"41","author":"Fishman","year":"2020","journal-title":"Semin Respir Crit Care Med."},{"issue":"9","key":"2022021511371258900_CIT0059","doi-asserted-by":"crossref","first-page":"e13587","DOI":"10.1111\/ctr.13587","article-title":"Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin Transplant"},{"issue":"12","key":"2022021511371258900_CIT0060","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1016\/j.radcr.2021.09.002","article-title":"Concurrent COVID-19 and Pneumocystis jirovecii pneumonia: the importance of radiological diagnostic and HIV testing","volume":"16","author":"Anggraeni","year":"2021","journal-title":"Radiol Case Rep."},{"issue":"6","key":"2022021511371258900_CIT0061","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s15010-021-01630-9","article-title":"Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization?","volume":"49","author":"Chong","year":"2021","journal-title":"Infection."},{"issue":"21","key":"2022021511371258900_CIT0062","doi-asserted-by":"crossref","first-page":"11399","DOI":"10.3390\/ijerph182111399","article-title":"Pneumocystis jirovecii pneumonia in non-HIV patients recovering from COVID-19: a single-center experience","volume":"18","author":"Gentile","year":"2021","journal-title":"Int J Environ Res Public Health."},{"issue":"2","key":"2022021511371258900_CIT0063","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11102-010-0256-1","article-title":"Prophylactic antibiotic trends in transsphenoidal surgery for pituitary lesions","volume":"14","author":"Little","year":"2011","journal-title":"Pituitary."},{"key":"2022021511371258900_CIT0064","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.wneu.2019.05.082","article-title":"A systematic review of prophylactic antibiotic use in endoscopic endonasal transsphenoidal surgery for pituitary lesions","volume":"128","author":"Moldovan","year":"2019","journal-title":"World Neurosurg."},{"key":"2022021511371258900_CIT0065","first-page":"1","article-title":"Endocrine risk factors for COVID-19: endogenous and exogenous glucocorticoid excess","author":"Vogel","year":"2021","journal-title":"Rev Endocr Metab Disord."},{"issue":"3","key":"2022021511371258900_CIT0066","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis."},{"issue":"4","key":"2022021511371258900_CIT0067","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-17-0997","article-title":"Preoperative medical treatment in Cushing\u2019s syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN","volume":"178","author":"Valassi","year":"2018","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2022021511371258900_CIT0068","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11102-020-01059-7","article-title":"Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic\u2013an international perspective","volume":"23","author":"Fleseriu","year":"2020","journal-title":"Pituitary."},{"issue":"1","key":"2022021511371258900_CIT0069","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-20-0352","article-title":"Endocrinology in the time of COVID-19: management of Cushing\u2019s syndrome","volume":"183","author":"Newell-Price","year":"2020","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2022021511371258900_CIT0070","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/cen.12286","article-title":"Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing\u2019s disease","volume":"80","author":"van den Bosch","year":"2014","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"11","key":"2022021511371258900_CIT0071","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","article-title":"Incidence of venous thromboembolism in patients with Cushing\u2019s syndrome: a multicenter cohort study","volume":"96","author":"Stuijver","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022021511371258900_CIT0072","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-20-0380","article-title":"Etomidate infusion at low doses is an effective and safe treatment for severe Cushing\u2019s syndrome outside intensive care","volume":"183","author":"Constantinescu","year":"2020","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2022021511371258900_CIT0073","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1210\/jc.2018-02080","article-title":"Tumor-directed therapeutic targets in Cushing disease","volume":"104","author":"Theodoropoulou","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022021511371258900_CIT0074","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11102-019-01021-2","article-title":"Pasireotide treatment significantly reduces tumor volume in patients with Cushing\u2019s disease: results from a phase 3 study","volume":"23","author":"Lacroix","year":"2020","journal-title":"Pituitary."},{"issue":"5","key":"2022021511371258900_CIT0075","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing\u2019s disease: is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2022021511371258900_CIT0076","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2265.2012.04424.x","article-title":"A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing\u2019s syndrome","volume":"77","author":"Valassi","year":"2012","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2022021511371258900_CIT0077","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s12020-018-1675-4","article-title":"Metyrapone treatment in Cushing\u2019s syndrome: a real-life study","volume":"62","author":"Ceccato","year":"2018","journal-title":"Endocrine."},{"issue":"6","key":"2022021511371258900_CIT0078","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1210\/jcem-63-6-1365","article-title":"Use of ketoconazole in the treatment of Cushing\u2019s syndrome","volume":"63","author":"Loli","year":"1986","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022021511371258900_CIT0079","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11102-015-0692-z","article-title":"Osilodrostat, a potent oral 11\u03b2-hydroxylase inhibitor: 22-week, prospective, phase II study in Cushing\u2019s disease","volume":"19","author":"Fleseriu","year":"2016","journal-title":"Pituitary."},{"issue":"11","key":"2022021511371258900_CIT0080","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-8587(19)30313-4","article-title":"Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing\u2019s syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial","volume":"7","author":"Fleseriu","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"2022021511371258900_CIT0081","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing\u2019s syndrome: a consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022021511371258900_CIT0082","first-page":"440","article-title":"Diagnosis and management of Cushing\u2019s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis","volume":"84","author":"Invitti","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022021511371258900_CIT0083","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1210\/jc.2003-030751","article-title":"Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing\u2019s disease","volume":"88","author":"Pereira","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022021511371258900_CIT0084","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-010-9140-6","article-title":"Peri-operative management of Cushing\u2019s disease","volume":"11","author":"AbdelMannan","year":"2010","journal-title":"Rev Endocr Metab Disord."},{"issue":"5","key":"2022021511371258900_CIT0085","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3171\/2017.6.JNS17635","article-title":"Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing\u2019s disease: implications for immediate reoperation and remission","volume":"129","author":"Mayberg","year":"2018","journal-title":"J Neurosurg."},{"issue":"4","key":"2022021511371258900_CIT0086","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11102-012-0455-z","article-title":"Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing\u2019s disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience","volume":"16","author":"Hameed","year":"2013","journal-title":"Pituitary."},{"issue":"5","key":"2022021511371258900_CIT0087","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11102-020-01066-8","article-title":"Outcomes of pituitary surgery for Cushing\u2019s disease: a systematic review and meta-analysis","volume":"23","author":"Stroud","year":"2020","journal-title":"Pituitary."},{"issue":"7","key":"2022021511371258900_CIT0088","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1210\/jc.2011-0456","article-title":"The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing\u2019s disease after transsphenoidal surgery","volume":"96","author":"Lindsay","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022021511371258900_CIT0089","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1210\/jc.2005-1204","article-title":"Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing\u2019s disease","volume":"91","author":"Esposito","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022021511371258900_CIT0090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1210\/jc.2009-1672","article-title":"Delayed remission after transsphenoidal surgery in patients with Cushing\u2019s disease","volume":"95","author":"Valassi","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022021511371258900_CIT0091","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/EJE-17-0873","article-title":"Earlier post-operative hypocortisolemia may predict durable remission from Cushing\u2019s disease","volume":"178","author":"Ironside","year":"2018","journal-title":"Eur J Endocrinol."},{"issue":"9","key":"2022021511371258900_CIT0092","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1530\/EC-19-0297","article-title":"Prognostic usefulness of ACTH in the postoperative period of Cushing\u2019s disease","volume":"8","author":"Abell\u00e1n-Galiana","year":"2019","journal-title":"Endocr Connect."},{"issue":"10","key":"2022021511371258900_CIT0093","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s701-002-8284-y","article-title":"Intra- and postoperative plasma ACTH concentrations in patients with Cushing\u2019s disease cured by transsphenoidal pituitary surgery","volume":"144","author":"Czirj\u00e1k","year":"2002","journal-title":"Acta Neurochir (Wien)."},{"issue":"1","key":"2022021511371258900_CIT0094","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12020-020-02247-y","article-title":"Postoperative management of patients with pituitary tumors submitted to pituitary surgery. Experience of a Spanish Pituitary Tumor Center of Excellence","volume":"69","author":"Araujo-Castro","year":"2020","journal-title":"Endocrine."},{"key":"2022021511371258900_CIT0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/B978-0-12-819949-7.00047-0","article-title":"Perioperative endocrinological management in patients with pituitary adenomas","volume-title":"Pituitary Tumors: a Comprehensive and Interdisciplinary Approach.","author":"Fountas","year":"2021"},{"issue":"4","key":"2022021511371258900_CIT0096","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing\u2019s disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev."},{"key":"2022021511371258900_CIT0097","first-page":"1","article-title":"Pituitary Society Delphi Survey: an international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas","author":"Tritos","year":"2021"},{"issue":"1","key":"2022021511371258900_CIT0098","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3171\/JNS\/2008\/108\/01\/0009","article-title":"Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years","volume":"108","author":"Hofmann","year":"2008","journal-title":"J Neurosurg."},{"issue":"4","key":"2022021511371258900_CIT0099","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/EJE-15-1226","article-title":"Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre","volume":"174","author":"Witek","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2022021511371258900_CIT0100","doi-asserted-by":"crossref","first-page":"R227","DOI":"10.1530\/EJE-14-0883","article-title":"Therapy of endocrine disease: outcomes in patients with Cushing\u2019s disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence","volume":"172","author":"Petersenn","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2022021511371258900_CIT0101","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5114\/fn.2020.102438","article-title":"MGMT expression in pituitary corticotroph adenomas and its relationship to clinical, pathological, and ultrastructural parameters in patients with Cushing\u2019s disease","volume":"58","author":"Witek","year":"2020","journal-title":"Folia Neuropathol."},{"issue":"4","key":"2022021511371258900_CIT0102","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11102-019-00973-9","article-title":"Cushing\u2019s disease due to somatic USP8 mutations: a systematic review and meta-analysis","volume":"22","author":"Wanichi","year":"2019","journal-title":"Pituitary."},{"issue":"1)","key":"2022021511371258900_CIT0103","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1210\/clinem\/dgab659","article-title":"Diagnostic pitfalls in Cushing\u2019s disease impacting surgical remission rates; test thresholds and lessons learned in 105 patients","volume":"107","author":"Mallari","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"2022021511371258900_CIT0104","doi-asserted-by":"crossref","first-page":"620005","DOI":"10.3389\/fendo.2021.620005","article-title":"Significance of Crooke\u2019s hyaline change in nontumorous corticotrophs of patients with Cushing disease","volume":"12","author":"Akirov","year":"2021","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"5","key":"2022021511371258900_CIT0105","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/EJE-18-0694","article-title":"Should we avoid using ketoconazole in patients with severe Cushing\u2019s syndrome and increased levels of liver enzymes?","volume":"179","author":"Ollivier","year":"2018","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2022021511371258900_CIT0106","first-page":"1776","article-title":"Intraoperative adrenocorticotropin levels during transsphenoidal surgery for Cushing\u2019s disease do not predict cure","volume":"82","author":"Graham","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2022021511371258900_CIT0107","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.eprac.2021.07.003","article-title":"Fluid restriction after transsphenoidal surgery for the prevention of delayed hyponatremia: a systematic review and meta-analysis","volume":"27","author":"Perez-Vega","year":"2021","journal-title":"Endocr Pract."},{"issue":"4","key":"2022021511371258900_CIT0108","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1210\/er.2001-0014","article-title":"Endocrine withdrawal syndromes","volume":"24","author":"Hochberg","year":"2003","journal-title":"Endocr Rev."},{"issue":"2","key":"2022021511371258900_CIT0109","doi-asserted-by":"crossref","first-page":"101489","DOI":"10.1016\/j.beem.2021.101489","article-title":"The role of reoperation after recurrence of Cushing\u2019s disease","volume":"35","author":"Cardinal","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"2022021511371258900_CIT0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.wneu.2016.01.022","article-title":"Predictors and rates of delayed symptomatic hyponatremia after transsphenoidal surgery: a systematic review [corrected]","volume":"88","author":"Cote","year":"2016","journal-title":"World Neurosurg."},{"issue":"4","key":"2022021511371258900_CIT0111","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1365-2265.1999.00666.x","article-title":"Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas","volume":"50","author":"Hensen","year":"1999","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"5","key":"2022021511371258900_CIT0112","first-page":"1395","article-title":"Hyponatremia after transsphenoidal surgery for pituitary tumors","volume":"79","author":"Sane","year":"1994","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022021511371258900_CIT0113","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11102-006-9276-2","article-title":"Disorders of water metabolism following transsphenoidal pituitary surgery: a single institution\u2019s experience","volume":"9","author":"Adams","year":"2006","journal-title":"Pituitary."},{"issue":"1","key":"2022021511371258900_CIT0114","doi-asserted-by":"crossref","first-page":"16","DOI":"10.14791\/btrt.2021.9.e5","article-title":"Delayed hyponatremia after transsphenoidal surgery for pituitary adenomas: a single institutional experience","volume":"9","author":"Hong","year":"2021","journal-title":"Brain Tumor Res Treat."},{"issue":"1","key":"2022021511371258900_CIT0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1753-0407.12090","article-title":"Glucocorticoid-induced hyperglycemia","volume":"6","author":"Perez","year":"2014","journal-title":"J Diabetes."},{"issue":"1","key":"2022021511371258900_CIT0116","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11102-017-0843-5","article-title":"A practical method for prevention of readmission for symptomatic hyponatremia following transsphenoidal surgery","volume":"21","author":"Burke","year":"2018","journal-title":"Pituitary."},{"issue":"5","key":"2022021511371258900_CIT0117","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3171\/2017.12.JNS172318","article-title":"Complications associated with microscopic and endoscopic transsphenoidal pituitary surgery: experience of 1153 consecutive cases treated at a single tertiary care pituitary center","volume":"130","author":"Agam","year":"2018","journal-title":"J Neurosurg."},{"issue":"8","key":"2022021511371258900_CIT0118","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/jnnp-2012-303194","article-title":"Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis","volume":"84","author":"Ammirati","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"3","key":"2022021511371258900_CIT0119","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3171\/jns.2005.103.3.0448","article-title":"Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients","volume":"103","author":"Nemergut","year":"2005","journal-title":"J Neurosurg."},{"issue":"20","key":"2022021511371258900_CIT0120","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1056\/NEJMcp066837","article-title":"Clinical practice. The syndrome of inappropriate antidiuresis","volume":"356","author":"Ellison","year":"2007","journal-title":"N Engl J Med."},{"issue":"4","key":"2022021511371258900_CIT0121","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0885066614566794","article-title":"Hyponatremia: a review","volume":"31","author":"Buffington","year":"2016","journal-title":"J Intensive Care Med."},{"issue":"6","key":"2022021511371258900_CIT0122","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2265.2012.04442.x","article-title":"ACTH-secreting pituitary microadenomas are associated with a higher prevalence of central hypothyroidism compared to other microadenoma types","volume":"77","author":"Mathioudakis","year":"2012","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2022021511371258900_CIT0123","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1210\/clinem\/dgaa858","article-title":"The hypothalamic-pituitary-thyroid axis in Cushing syndrome before and after curative surgery","volume":"106","author":"Shekhar","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"key":"2022021511371258900_CIT0124","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/B978-0-12-819949-7.00013-5","article-title":"Pituitary magnetic resonance imaging use in the posttreatment follow-up of secreting pituitary adenomas","volume-title":"Pituitary Tumors.","author":"Hinojosa-Amaya","year":"2021"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvac010\/42323684\/bvac010.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/6\/3\/bvac010\/42531678\/bvac010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/6\/3\/bvac010\/42531678\/bvac010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T11:49:35Z","timestamp":1644925775000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvac010\/6516798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":124,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvac010","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2022,1,28]]},"article-number":"bvac010"}}